These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 25943633

  • 1. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
    Ren YQ, Fu F, Han J.
    Med Sci Monit; 2015 May 06; 21():1297-303. PubMed ID: 25943633
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L.
    Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450
    [Abstract] [Full Text] [Related]

  • 3. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC, Wang JX, Han ML, Zhang LP, Li L.
    Cell Oncol (Dordr); 2017 Apr 21; 40(2):157-166. PubMed ID: 28054302
    [Abstract] [Full Text] [Related]

  • 4. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J, Lai Y, Ma J, Liu Y, Bi J, Zhang L, Chen L, Yao C, Lv W, Chang G, Wang S, Ouyang M, Wang W.
    BMC Cancer; 2017 Nov 10; 17(1):745. PubMed ID: 29126392
    [Abstract] [Full Text] [Related]

  • 5. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J, Shin VY, Siu MT, Ho JC, Cheuk I, Kwong A.
    BMC Cancer; 2016 Nov 14; 16(1):887. PubMed ID: 27842518
    [Abstract] [Full Text] [Related]

  • 6. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA.
    Oncotarget; 2016 Apr 12; 7(15):19519-30. PubMed ID: 26799586
    [Abstract] [Full Text] [Related]

  • 7. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F, Luo N, Hu Y, Li X, Zhang K.
    Cell Physiol Biochem; 2018 Apr 12; 47(5):2147-2158. PubMed ID: 29975921
    [Abstract] [Full Text] [Related]

  • 8. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L.
    Cell Physiol Biochem; 2018 Apr 12; 48(5):1968-1982. PubMed ID: 30092563
    [Abstract] [Full Text] [Related]

  • 9. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
    Kim YJ, Choi JS, Seo J, Song JY, Lee SE, Kwon MJ, Kwon MJ, Kundu J, Jung K, Oh E, Shin YK, Choi YL.
    Int J Cancer; 2014 May 15; 134(10):2424-36. PubMed ID: 24615768
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer.
    Yu J, Shen W, Gao B, Zhao H, Xu J, Gong B.
    Neoplasma; 2017 May 15; 64(2):209-215. PubMed ID: 28043147
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.
    Assani G, Segbo J, Yu X, Yessoufou A, Xiong Y, Zhou F, Zhou Y.
    Asian Pac J Cancer Prev; 2019 Dec 01; 20(12):3679-3687. PubMed ID: 31870109
    [Abstract] [Full Text] [Related]

  • 12. MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.
    Zheng M, Wu Z, Wu A, Huang Z, He N, Xie X.
    Tumour Biol; 2016 Jul 01; 37(7):8599-607. PubMed ID: 26733177
    [Abstract] [Full Text] [Related]

  • 13. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
    Jang NY, Kim DH, Cho BJ, Choi EJ, Lee JS, Wu HG, Chie EK, Kim IA.
    BMC Cancer; 2015 Mar 03; 15():89. PubMed ID: 25884663
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.
    Tang L, Wei D, Yan F.
    Cancer Gene Ther; 2016 Aug 03; 23(8):258-65. PubMed ID: 27364572
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T, Cheng Y, She Q, Jiang Y, Chen Y, Yang W, Li Y.
    Biomed Pharmacother; 2018 Nov 03; 107():338-346. PubMed ID: 30098551
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
    Song H, Li D, Wu T, Xie D, Hua K, Hu J, Deng X, Ji C, Deng Y, Fang L.
    BMB Rep; 2018 Nov 03; 51(11):602-607. PubMed ID: 30269739
    [Abstract] [Full Text] [Related]

  • 17. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H, Pan H, Qian Y, Zhou W, Liu X.
    Mol Cancer; 2018 Jan 08; 17(1):4. PubMed ID: 29310680
    [Abstract] [Full Text] [Related]

  • 18. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY.
    BMC Cancer; 2016 Feb 25; 16():160. PubMed ID: 26917489
    [Abstract] [Full Text] [Related]

  • 19. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F, Zhuang L, Wu R, Li D.
    J BUON; 2019 Feb 25; 24(5):1905-1912. PubMed ID: 31786854
    [Abstract] [Full Text] [Related]

  • 20. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Jia Z, Liu Y, Gao Q, Han Y, Zhang G, Xu S, Cheng K, Zou W.
    Gene; 2016 Nov 15; 593(1):41-47. PubMed ID: 27506313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.